BI Pancreatic Cancer Disease Hub: A $16 Billion Market Ready to Launch: BI Replay
This webinar will detail the current working assumptions and sales forecasts of Bloomberg Intelligence’s pancreatic cancer Disease Hub, one of over 20 proprietary and interactive cancer models that are now live on the Terminal. Each Disease Hub is used to assess the market dynamics and estimate peak and risk adjusted sales potential for that indication. Please join Anna Wernick, pancreatic cancer Disease Specialist and Javier Manso Polo, Pharma & Biotech analyst, for the discussion.